alpha-aminopyridine has been researched along with Brain Stem Neoplasms, Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
DeBlank, P; DeWire-Schottmiller, MD; Fouladi, M; Gilligan, LA; Leach, JL | 1 |
Breneman, J; Carle, AC; Chow, LML; de Blank, P; DeWire, M; Dexheimer, P; Drissi, R; Fouladi, M; Fuller, C; Hummel, TR; Jones, BV; Kumar, SS; Lane, A; Lawson, S; Leach, JL; Pater, L; Salloum, R; Stevenson, CB; Witte, D; Zhu, X | 1 |
2 trial(s) available for alpha-aminopyridine and Brain Stem Neoplasms, Primary
Article | Year |
---|---|
Tumor Response Assessment in Diffuse Intrinsic Pontine Glioma: Comparison of Semiautomated Volumetric, Semiautomated Linear, and Manual Linear Tumor Measurement Strategies.
Topics: Adolescent; Aminopyridines; Brain Stem Neoplasms; Chemoradiotherapy; Chemotherapy, Adjuvant; Child; Diffuse Intrinsic Pontine Glioma; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Purines; Software; Tumor Burden; Young Adult | 2020 |
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
Topics: Adolescent; Adult; Aminopyridines; Brain Stem Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Diffuse Intrinsic Pontine Glioma; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Prognosis; Purines; Tissue Distribution; Young Adult | 2020 |